Dr. Murugesan Manoharan, MD – Miami, FL
Mia Fernandez Overview of Dr. Manoharan
Dr. M. Manoharan MD, FRCS(Eng), FRACS(Urol) is the "Chief of Urologic Oncology and the Director of Robotic Urologic Surgery" at the "Miami Cancer Institute, Baptist Health South Florida, Miami, USA ". He is internationally known for his expertise in Urologic Oncology, Robotic surgery, Neobladder reconstruction and other urinary reconstruction . He has served a member in the International bladder cancer guidelines committee. He has delivered several lectures in both national and international scientific meetings and conducted urological workshops. He has published more than 140 articles in peer reviewed journals and authored 15 text book chapters. He is an active investigator in several Urologic Oncology research studies. He completed his urology training in New Zealand and Urologic Oncology training at University of Miami.
Clinical Expertise
- Minimally invasive urologic surgery, Urologic oncology, Robotic surgery, laparoscopic surgery, urologic oncology, reconstruction, Robotic prostatectomy, Orthotopic bladder substitution, Robotic partial nephrectomy, Robotic nephrectomy, Radical cystectomy, Lymphadenectomy, Ureteral reconstruction, Ileal conduit, Ben ign prostatic hyperplasia, Greenlight laser therapy for benign prostatic hyperplasia, Urethral cancer, Micropapillary carcinoma
Education & Training
University of Miami Hospital and ClinicsFellowship, Urologic Surgical Oncology, 2002 - 2003
Madras Medical CollegeClass of 1988
Certifications & Licensure
FL State Medical License 2003 - 2025
IN State Medical License 2005 - 2017
IA State Medical License 2005 - 2015
- American Board of Urology Urology
Awards, Honors, & Recognition
- Best Urology Teacher of the Year Department of Urology, University of Miami, 2004, 2007, 2009, 2013, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
Irreversible electroporation as a focal therapy for localized prostate cancer: A systematic review.
Prabhakar, P., Avudaiappan, A., Sandman, M., Eldefrawy, A., Caso, J., Narayanan, G., Manoharan, M.> ;Indian Journal of Urology. 2023 Dec 29Propensity score matched survival analysis of octogenarians with muscle-invasive bladder cancer: chemoradiation compared to radical cystectomy.
Arjun Pon Avudaiappan, Pushan Prabhakar, Hariharan Ganapathi, Nathan VanderVeer-Harris, Jorge Caso, Rohan Garje, Murugesan Manoharan> ;The Canadian Journal of Urology. 2023 Oct 1- 1 citations
Surgeon administered transversus abdominis plane block: anatomic principles and technique.
Pushan Prabhakar, Hariharan Palayapalayam Ganapathi, Vishnu Suresh, Anthony Farias, Murugesan Manoharan> ;Journal of Robotic Surgery. 2023 Aug 1 - Join now to see all
Press Mentions
The Challenges with Using Targeted Therapies in Ovarian Cancer SpaceMarch 25th, 2023
New Technology Leads to More Accurate Prostate Cancer Diagnosis and TreatmentsMay 24th, 2021
Miami Cancer Institute Names Murugesan Manoharan, as Chief of Urologic Oncology SurgeryFebruary 19th, 2017
- Join now to see all